Mucosta

Mucosta

rebamipide

Manufacturer:

Otsuka (Philippines)

Distributor:

Zuellig
Concise Prescribing Info
Contents
Rebamipide
Indications/Uses
Gastric mucosal lesions (erosion, bleeding, redness & edema) in acute gastritis & exacerbation of chronic gastritis; gastric ulcer; NSAID-induced gastropathy & enteropathy.
Dosage/Direction for Use
Gastric mucosal lesions in acute gastritis & acute exacerbation of chronic gastritis & gastric ulcer 1 tab tid to be taken in the morning, evening & before bedtime. NSAID-induced gastropathy & enteropathy 100 mg tid.
Administration
May be taken with or without food.
Contraindications
Special Precautions
Discontinue if markedly increase transaminase, fever, rash & hypersensitivity reactions develop. Pregnancy & lactation. Elderly. Childn.
Adverse Reactions
Rash, pruritus, drug-eruption-like eczema, other symptoms of hypersensitivity; constipation, feeling of enlarged abdomen, diarrhea, nausea, vomiting, heartburn, abdominal pain, belching, abnormal taste; increased AST, ALT, γ-GTP, alkaline phosphatase levels; leukopenia, granulocytopenia; menstrual disorders, increased BUN levels, edema, feeling of a foreign body in the pharynx.
MIMS Class
Antacids, Antireflux Agents & Antiulcerants
ATC Classification
A02BX14 - rebamipide ; Belongs to the class of other drugs used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
Presentation/Packing
Form
Mucosta tab 100 mg
Packing/Price
100's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in